Splash
Splash

News & SEC Filings

News

View all news
13 October 2020Regulatory
Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

Posters highlight ensifentrine’s potential to provide rapid benefits LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will present

23 September 2020Regulatory
Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD

LONDON and RALEIGH, N.C., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of its ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”)

21 September 2020Regulatory
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (“MAR”). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN

17 September 2020Company News, Regulatory
Verona Pharma to Ring the Nasdaq Closing Bell to celebrate $200 million financing

LONDON and RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and CEO of Verona Pharma, will ring the

16 September 2020Regulatory
Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease

Publication highlights ensifentrine’s potential to provide rapid symptom relief LONDON and RALEIGH, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces

SEC Filings

Group

Year

DateDescriptionFormFiling GroupView
05 Oct 2020An amendment to a SC 13D filingSC 13D/AOther
25 Sep 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
22 Sep 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
14 Sep 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
27 Aug 2020EFFECTEFFECTOther
27 Aug 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
25 Aug 2020Amendment to a previously filed 6-K6-K/ACurrent Reports
25 Aug 2020This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
20 Aug 2020Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
19 Aug 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
17 Aug 2020Registration statement for certain foreign private issuersF-1Registration Statements
14 Aug 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
10 Aug 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
03 Aug 2020An amendment to a SC 13D filingSC 13D/AOther
31 Jul 2020An amendment to a SC 13D filingSC 13D/AOther
30 Jul 2020-DOther
24 Jul 2020A statement of beneficial ownership of common stock by certain personsSC 13GOther
24 Jul 2020An amendment to the SC 13G filingSC 13G/AOther
22 Jul 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
20 Jul 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
16 Jul 2020Amendment to a previously filed 20-F20-F/AAnnual Filings
14 May 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
30 Apr 2020Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
30 Apr 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
16 Apr 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
14 Apr 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
06 Apr 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
30 Mar 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
10 Mar 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
27 Feb 2020Registration of securities of foreign private issuers pursuant to section 12(b) or (g)20-FAnnual Filings
05 Feb 2020An amendment to the SC 13G filingSC 13G/AOther
04 Feb 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
17 Jan 2020Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
29 Nov 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
22 Nov 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
22 Nov 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
05 Nov 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
19 Sep 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
14 Aug 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
08 Aug 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
07 Aug 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
05 Jun 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
14 May 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
07 May 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
03 May 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
12 Apr 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
02 Apr 2019Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
26 Mar 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
26 Mar 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
19 Mar 2019Registration of securities of foreign private issuers pursuant to section 12(b) or (g)20-FAnnual Filings
12 Mar 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
28 Feb 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
12 Feb 2019An amendment to the SC 13G filingSC 13G/AOther
11 Feb 2019An amendment to the SC 13G filingSC 13G/AOther
04 Jan 2019Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
06 Nov 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
25 Sep 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
14 Aug 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
07 Aug 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
28 Jun 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
04 Jun 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
01 Jun 2018EFFECTEFFECTOther
22 May 2018Registration statement for certain foreign private issuers offered for certain transactionsF-3Registration Statements
08 May 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
04 May 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
04 May 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
18 Apr 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
29 Mar 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
22 Mar 2018Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
27 Feb 2018Annual Report of foreign issuer rules 13 and 15(d) of the Securities Exchange Act20-FAnnual Filings
13 Feb 2018An amendment to the SC 13G filingSC 13G/AOther
06 Feb 2018An amendment to the SC 13G filingSC 13G/AOther
26 Jan 2018An amendment to a SC 13D filingSC 13D/AOther
09 Nov 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
21 Sep 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
12 Sep 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
24 Aug 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
08 Aug 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
26 May 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
18 May 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
12 May 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
09 May 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
09 May 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
08 May 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
08 May 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
08 May 2017Filing by person(s) reporting owned shares of common stock in a public company >5%SC 13DOther
05 May 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
05 May 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
03 May 2017Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act6-KCurrent Reports
01 May 2017CT ORDERCT ORDEROther
28 Apr 2017Securities offered to employees pursuant to employee benefit plansS-8Registration Statements
28 Apr 2017Form of prospectus disclosing information facts events covered in both forms 424B1 424B3424B4Registration Statements
26 Apr 2017Registration of up to an additional 20% of securities for an offering filed on an F-1F-1MEFRegistration Statements
26 Apr 2017EFFECTEFFECTOther
26 Apr 2017EFFECTEFFECTOther
26 Apr 2017This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
21 Apr 2017CERTNASCERTNASOther
19 Apr 2017Registration of certain classes of securities 12(b) of the Securities Exchange Act8-A12BRegistration Statements
19 Apr 2017CERTNASCERTNASOther
18 Apr 2017This filing is a pre-effective amendment to an F-1 filingF-1/ARegistration Statements
18 Apr 2017Registration of depository shares evidenced by American Depository ReceiptsF-6Registration Statements
03 Apr 2017Registration statement for certain foreign private issuersF-1Registration Statements
13 Feb 2017A statement of beneficial ownership of common stock by certain personsSC 13GOther
20 Jul 2016-DOther
Splash

© Verona Pharma plc 2020. All rights reserved